首页> 外国专利> BILIRUBIN OR BILIVERDIN DEGRADATION FRAGMENTS

BILIRUBIN OR BILIVERDIN DEGRADATION FRAGMENTS

机译:BILIRUBIN或BILIVERDIN降解片段

摘要

A pharmaceutical composition comprising a compound of formula (I) wherein X is an electron withdrawing group, YSUP1 /SUPis hydrogen, alkyl, alkenyl, alkynyl, aryl, heterocyclyl, -SOSUB2/SUBRSUP4/SUP, -COSUB2/SUBRSUP4/SUP, -CONHRSUP4 /SUPor -CORSUP4/SUP, and each of RSUP1/SUP, RSUP2 /SUPand RSUP4/SUP, which may be the same or different, is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl or heterocyclyl, or a compound of formula (II) wherein each of YSUP2 /SUPand YSUP3/SUP, which may be the same or different, is hydrogen, alkyl, alkenyl, alkynyl, aryl, heterocyclyl, -SOSUB2/SUBRSUP9/SUP, -COSUB2/SUBRSUP9/SUP, -CONHRSUP9 /SUPor -CORSUP9/SUP, Z is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heterocyclyl, -CH-C(NHRSUP10/SUP)CH((CHSUB2/SUB)SUBm/SUBCOSUB2/SUBRSUP11/SUP)(C-O)CHSUB3 /SUBor -CHSUB2/SUB(C-O)CH((CHSUB2/SUB)SUBm/SUBCOSUB2/SUBRSUP11/SUP)(C-O)CHSUB3/SUB, RSUP8 /SUPis -(CHSUB2/SUB)SUBn/SUBCOSUB2/SUBRSUP12/SUP, each of RSUP5 /SUPto RSUP7 /SUPand RSUP9 /SUPto RSUP12/SUP, which may be the same or different, is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl or heterocyclyl, and each of m and n, which may be the same or different, is 1 to 6 or a compound of formula (III) wherein each of YSUP4 /SUPto YSUP6/SUP, which may be the same or different, is hydrogen, alkyl, alkenyl, alkynyl, aryl, heterocyclyl, -SOSUB2/SUBRSUP19/SUP, -COSUB2/SUBRSUP19/SUP, -CONHRSUP19 /SUPor -CORSUP19/SUP, each of RSUP16 /SUPand RSUP17/SUP, which may be the same or different, is -(CHSUB2/SUB)SUBp/SUBCOSUB2/SUBRSUP20/SUP, each of RSUP13 /SUPTO RSUP15 /SUPand RSUP18 /SUPto RSUP20/SUP, which may be the same or different, is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl or heterocyclyl, and p is 1 to 6, or other photolabile degradation product of bilirubin or biliverdin or derivative of a photolabile degradation fragment of bilirubin or biliverdin, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier or diluent
机译:包含其中X为吸电子基团,Y 1 为氢,烷基,烯基,炔基,芳基,杂环基,-SO 2 R 4 ,-CO 2 R 4 ,-CONHR 4 或-COR 4 ,R 1 ,R 2 和R 4 中的每一个可以相同或不同,分别是氢,烷基,环烷基,烯基,环烯基,炔基,芳基或杂环基,或式(II)的化合物,其中每个Y 2 和Y 3 可以相同或不同,是氢,烷基,烯基,炔基,芳基,杂环基,-SO 2 R 9 ,-CO 2 R 9 ,-CONHR 9 或-COR 9 ,Z为氢,烷基,环烷基,烯基,环烯基,炔基,芳基,杂环基,-CH-C(NHR < SUP> 10 )CH((CH 2 m CO 2 R 11 )(CO )CH 3 或-CH 2 (CO)CH((CH 2 m CO 2 R 11 )(CO)CH 3 ,R 8 是-(CH 2 n CO 2 R 12 ,每个R 5 至R 7 和R 9 至可以相同或不同的R 12 是氢,烷基,环烷基,烯基,环烯基,炔基,芳基或杂环基,并且m和n分别相同或不同,是1至6或式(III)的化合物,其中每个Y 4 至Y 6 可以相同或不同,为氢,烷基,烯基,炔基,芳基,杂环基,-SO 2 R 19 ,-CO 2 R 19 ,-CONHR 19 或-COR 19 ,R 16 和R 17 中的每一个(可能相同或不同)是- (CH 2 p CO 2 R 20 ,每个R 13 TO R 15 和R 18 至R 20 可以相同或不同,是氢,烷基,环烷基,烯基,环烯基,炔基,芳基或杂环基,且p为1到6,或胆红素或联肝素的其他光不稳定降解产物或胆红素或联肝素的光不稳定降解片段的衍生物,或其药学上可接受的盐,以及药学上可接受的载体或稀释剂

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号